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Your sharp-eyed editor has his eyes drawn to rec-
ommendations to prescribe amore expensive therapy.
Prescribing support software is widely used and
designed to improve prescribing by recommending
more cost-eﬀective prescriptions. Sometimes this is
done by recommending generics and sometimes by
suggesting alternative agents. A recent article in Pre-
scriber describes its functionality in detail.1
Nearly always the recommendation is for cheaper
preparations. However, these screen shots show a
more expensive recommendation (Figure 1)!
Figure 1 Recommendation for higher cost prescribing
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The Editor would be delighted to hear if this is an
isolated problem or one that other readers of the
journal have seen. Also, can readers suggest reasons
for this? These prompts appeared in late February
2008, though one of the notes within the guidance
note relates to 2007. Whilst the recommended substi-
tutions are either cheaper per gram of cream or per
tablet because the quantities substituted are greater
the prescription is more expensive. Further enquiries
revealed that the people loading the ‘rules’ into the
prescribing support software were not aware that their
implication might be more expensive prescriptions.
They also did not have sight of how the rules they were
loading appeared in front of the clinicians using the
prescribing support application. There are lessons from
this:
1 Clinicians need to watch prescribing support soft-
ware carefully. It is possible to create rules within it
that recommends a ‘negative beneﬁt’ i.e. a more
expensive prescription.
2 Managers and clinicians loading guidance need to
take account of diﬀerent size containers and num-
bers of tablets recommended as this can change the
ﬁnal cost to the health service.
3 It may be undesirable for applications to be
designed in a way that allows ‘negative beneﬁts’
to be generated, or for those loading the rules not to
have a ‘clinician view’.
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